Effect of sleep apnea on cognition and mood
暂无分享,去创建一个
[1] D. Giles,et al. Beta EEG activity and insomnia. , 2001, Sleep medicine reviews.
[2] R. Farinotti,et al. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[3] E. Bixler,et al. Insomnia in central Pennsylvania. , 2002, Journal of psychosomatic research.
[4] D. Clody,et al. A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine Hypnotic , 1994, Journal of clinical pharmacology.
[5] E. Bixler,et al. Biopsychobehavioral correlates of insomnia, III: Polygraphic findings of sleep difficulty and their relationship to psychopathology. , 1984, The International journal of neuroscience.
[6] Y. Lecrubier,et al. Form, frequency and burden of sleep problems in general health care: a report from the WHO Collaborative Study on Psychological Problems in General Health Care , 1996, European Psychiatry.
[7] E. Bixler,et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. , 2001, The Journal of clinical endocrinology and metabolism.
[8] F. Richer,et al. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). , 1993, Journal of clinical and experimental neuropsychology.
[9] L. Bailey,et al. Clinical Pharmacokinetics of Benzodiazipines , 1994, Journal of clinical pharmacology.
[10] M. Weissman,et al. The morbidity of insomnia uncomplicated by psychiatric disorders. , 1997, General hospital psychiatry.
[11] L. Gustavson,et al. The clinical pharmacokinetics of single doses of estazolam. , 1990, The American journal of medicine.
[12] C. Mervis,et al. Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder. , 2003, Pediatrics.
[13] E M Badley,et al. Insomnia and health problems in Canadians. , 2001, Sleep.
[14] M. Thorpy,et al. Treatment of chronic insomnia by restriction of time in bed. , 1987, Sleep.
[15] S. Ancoli-Israel,et al. Neuropsychological Effects of One-Week Continuous Positive Airway Pressure Treatment in Patients With Obstructive Sleep Apnea: A Placebo-Controlled Study , 2001, Psychosomatic medicine.
[16] A. Lewy,et al. Entrainment of free-running circadian rhythms by melatonin in blind people. , 2000, The New England journal of medicine.
[17] J. Piccirillo,et al. Learning, Memory, and Executive Control in Individuals With Obstructive Sleep Apnea Syndrome , 2002, Journal of clinical and experimental neuropsychology.
[18] ColinE. Sullivan,et al. REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.
[19] E. Rüther,et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. , 2001 .
[20] A. Kales,et al. Sleep and its disorders. , 1999, Annual review of medicine.
[21] J. Pépin,et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. , 1995, Sleep.
[22] D. Kupfer,et al. Depressive psychopathology in male sleep apneics. , 1984, The Journal of clinical psychiatry.
[23] I. Hickie,et al. Neurobehavioral Functioning in Obstructive Sleep Apnea: Differential Effects of Sleep Quality, Hypoxemia and Subjective Sleepiness , 2004, Journal of clinical and experimental neuropsychology.
[24] Susan Redline,et al. Sleep-disordered breathing and cognitive impairment in elderly Japanese-American men. , 2003, Sleep.
[25] D. Greenblatt,et al. The International Classification of Sleep Disorders , 1992 .
[26] J Zieliński,et al. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea , 1996, Journal of sleep research.
[27] Y. Dauvilliers,et al. Response to "Idiopathic hypersomnia: a diagnostic dilemma" (J. Montplaisir and L. Fantini). , 2001, Sleep medicine reviews.
[28] P. Benfield,et al. Zolpidem , 1990, Drugs.
[29] A. Kales,et al. Evaluation and Treatment of Insomnia , 1984 .
[30] E. Bixler,et al. Biopsychobehavioral Correlates of Insomnia. II. Pattern Specificity and Consistency with the Minnesota Multiphasic Personality Inventory , 1983, Psychosomatic medicine.
[31] D. Ford,et al. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.
[32] M. Bianchi,et al. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. , 1990, International clinical psychopharmacology.
[33] Charles M. Morin,et al. Insomnia: Psychological Assessment and Management , 1993 .
[34] C. Guilleminault,et al. Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. , 1984 .
[35] S. Kuna,et al. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. , 2001, American journal of respiratory and critical care medicine.
[36] R L Williams,et al. Prevalence of sleep disturbance in a primarily urban Florida County. , 1976, Social science & medicine.
[37] C. Espie,et al. Insomniacs' reported use of CBT components and relationship to long-term clinical outcome. , 2002, Behaviour research and therapy.
[38] N J Douglas,et al. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. , 1992, Archives of internal medicine.
[39] L. Kozlowski,et al. Over-the-counter sleep aids: Widely used but rarely studied , 1994 .
[40] Heinz Katschnig,et al. Diagnostic and statistical manual of mental disorders, third edition, revised (DSM-III-R) , 1992 .
[41] M Partinen,et al. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. , 1990, Chest.
[42] D. Gozal,et al. Increased susceptibility to intermittent hypoxia in aging rats: changes in proteasomal activity, neuronal apoptosis and spatial function , 2003, Journal of neurochemistry.
[43] C. Soldatos,et al. How do individuals sleep around the world? Results from a single-day survey in ten countries. , 2005, Sleep medicine.
[44] R. Bootzin,et al. Nonpharmacologic treatments of insomnia. , 1992, The Journal of clinical psychiatry.
[45] M. Lader. Rebound insomnia and newer hypnotics , 2005, Psychopharmacology.
[46] W. Mendelson,et al. MMPI correlates of sleep and respiratory disturbance in obstructive sleep apnea. , 1999, Sleep.
[47] E. Bixler,et al. Biopsychobehavioral correlates of insomnia, V: Clinical characteristics and behavioral correlates. , 1984, The American journal of psychiatry.
[48] R. Freedman,et al. Physiological and psychological factors in sleep-onset insomnia. , 1982, Journal of abnormal psychology.
[49] G. Nielsen. Brief integrative dynamic psychotherapy for insomnia. Systematic evaluation of two cases. , 1990, Psychotherapy and Psychosomatics.
[50] R. Millman,et al. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. , 1989, The Journal of clinical psychiatry.
[51] I. Oswald,et al. Physiological and psychological differences between good and poor sleepers. , 1986, Journal of psychiatric research.
[52] J. Yager,et al. Sleep Disorder Over Time: Psychiatric Correlates Among Males , 1980, British Journal of Psychiatry.
[53] R. Benca. Consequences of insomnia and its therapies. , 2001, The Journal of clinical psychiatry.
[54] F. Richer,et al. Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. , 1991, Journal of clinical and experimental neuropsychology.
[55] D. Deptula,et al. Neuropsychological dysfunction in sleep apnea. , 1987, Sleep.
[56] M. Scharf,et al. Comparative amnestic effects of benzodiazepine hypnotic agents. , 1988, The Journal of clinical psychiatry.
[57] D. Giles,et al. Temporal and stagewise distribution of high frequency EEG activity in patients with primary and secondary insomnia and in good sleeper controls , 2001, Journal of sleep research.
[58] C. Marra,et al. Does cognitive dysfunction conform to a distinctive pattern in obstructive sleep apnea syndrome? , 2004, Journal of sleep research.
[59] D. Katz,et al. Clinical correlates of insomnia in patients with chronic illness. , 1998, Archives of internal medicine.
[60] E. Kozminsky,et al. Adenotonsillectomy improves neurocognitive function in children with obstructive sleep apnea syndrome. , 2003, Sleep.
[61] David Gozal,et al. Neurobehavioral correlates of sleep‐disordered breathing in children , 2004, Journal of sleep research.
[62] D. Greenblatt,et al. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo , 1998, Clinical pharmacology and therapeutics.
[63] L. Johnson,et al. Rebound Insomnia: A Critical Review , 1989, Journal of clinical psychopharmacology.
[64] D. Pevernagie,et al. Executive function in sleep apnea: controlling for attentional capacity in assessing executive attention. , 2004, Sleep.
[65] C. Morin,et al. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. , 1994, The American journal of psychiatry.
[66] R. R. Greenson. The Technique and Practice of Psychoanalysis, Volume 1 , 1967 .
[67] J. Owens,et al. Sleep and Daytime Behavior in Children With Obstructive Sleep Apnea and Behavioral Sleep Disorders , 1998, Pediatrics.
[68] J. Alger,et al. Functional magnetic resonance imaging responses to expiratory loading in obstructive sleep apnea , 2003, Respiratory Physiology & Neurobiology.
[69] E. Bixler,et al. Next-day memory impairment with triazolam use , 1991, The Lancet.
[70] P. Hauri,et al. Persistent psychophysiologic (learned) insomnia. , 1986, Sleep.
[71] R. Barkin,et al. A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction. , 1999, Primary care companion to the Journal of clinical psychiatry.
[72] K. Greenwood,et al. Identifying effective psychological treatments for insomnia: A meta-analysis. , 1995 .
[73] L. Lavie,et al. Obstructive sleep apnoea syndrome--an oxidative stress disorder. , 2003, Sleep medicine reviews.
[74] Maree Barnes,et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. , 2002, American journal of respiratory and critical care medicine.
[75] D. Bliwise. Treating insomnia: pharmacological and nonpharmacological approaches. , 1991, Journal of psychoactive drugs.
[76] T. Roth,et al. Rebound insomnia: its determinants and significance. , 1990, The American journal of medicine.
[77] W. Mendelson,et al. A critical evaluation of the hypnotic efficacy of melatonin. , 1997, Sleep.
[78] P. Howard. Sleep Disorders Classification Committee, Association of Sleep Disorders Centers , 1979 .
[79] T. Karasu. Psychotherapies: an overview. , 1977, The American journal of psychiatry.
[80] C. Soldatos,et al. An integrative approach to the management of insomnia , 2003 .
[81] Vincent Ibanez,et al. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. , 2002, Sleep medicine.
[82] E. Bixler,et al. Onset of Insomnia: Role of Life‐Stress Events1 , 1981, Psychosomatic medicine.
[83] D. Gozal,et al. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits , 2002, Journal of sleep research.
[84] P. Hauri. Case Studies in Insomnia , 1991 .
[85] C. Guilleminault,et al. Insomnia and use of hypnotics: study of a French population. , 1991, Sleep.
[86] C. Morin,et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. , 1999, JAMA.
[87] J. Watson,et al. Psychiatric morbidity and illness behaviour in women with chronic pelvic pain. , 1994, Journal of psychosomatic research.
[88] S. F. Cappa,et al. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP) , 2003, Brain Research Bulletin.
[89] A. Kales,et al. Sleep disorders: insomnia, sleepwalking, night terrors, nightmares, and enuresis. , 1987, Annals of internal medicine.
[90] E. Bixler,et al. Prevalence of sleep disorders in the Los Angeles metropolitan area. , 1979, The American journal of psychiatry.
[91] M. Ohayon,et al. What are the contributing factors for insomnia in the general population? , 2001, Journal of psychosomatic research.
[92] J. D. Ball,et al. Sleep patterns among children with attention-deficit hyperactivity disorder: a reexamination of parent perceptions. , 1997, Journal of pediatric psychology.
[93] G. Hajak,et al. CONSENSUS FOR THE PHARMACOLOGICAL MANAGEMENT OF INSOMNIA IN THE NEW MILLENNIUM , 2001, International journal of clinical practice.
[94] J. Malin,et al. Neuropsychological investigations and event-related potentials in obstructive sleep apnea syndrome before and during CPAP-therapy , 1998, Journal of the Neurological Sciences.
[95] M. Schluchter,et al. Relation of measures of sleep-disordered breathing to neuropsychological functioning. , 2001, American journal of respiratory and critical care medicine.
[96] A. Kales,et al. Management of insomnia. , 1979, Annual review of medicine.
[97] S. Ancoli-Israel,et al. Effect of CPAP treatment on mood states in patients with sleep apnea. , 1999, Journal of psychiatric research.
[98] E. Bixler,et al. Hypnotic effectiveness of sodium salicylamide with short-term use: sleep laboratory studies. , 1978, Pharmacology.
[99] T. Roth,et al. Multiple Sleep Latency Test: Technical Aspects and Normal Values , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[100] M. Bonnet,et al. Insomnia, metabolic rate and sleep restoration , 2003, Journal of internal medicine.
[101] Y. Inoue,et al. Cerebral metabolic impairment in patients with obstructive sleep apnoea: an independent association of obstructive sleep apnoea with white matter change , 2001, Journal of neurology, neurosurgery, and psychiatry.
[102] Jeffry R Alger,et al. fMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects. , 2003, Journal of applied physiology.
[103] Daniel J Buysse,et al. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. , 2004, Sleep medicine reviews.
[104] C. Soldatos,et al. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. , 1999, International clinical psychopharmacology.
[105] T. Akashiba,et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. , 2002, Chest.
[106] S. Ancoli-Israel,et al. Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? , 2003, The American journal of psychiatry.
[107] T. Roth,et al. A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. , 2000, Sleep medicine.
[108] F. J. Nieto,et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. , 1999, American journal of respiratory and critical care medicine.
[109] C. Iber,et al. Measures of cognitive function in persons with varying degrees of sleep‐disordered breathing: the Sleep Heart Health Study , 2002, Journal of sleep research.
[110] J. Kelly,et al. Long-term changes in quality of life after surgery for pediatric obstructive sleep apnea. , 2004, Archives of otolaryngology--head & neck surgery.
[111] Lisa McLean. Overcoming Obstacles: Therapeutic Success Despite External Barriers. , 2002, Primary care companion to the Journal of clinical psychiatry.
[112] M. Johns,et al. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.
[113] Mary J Morrell,et al. Changes in brain morphology associated with obstructive sleep apnea. , 2003, Sleep medicine.
[114] T. Roth,et al. Efficacy and Tolerability of 14-Day Administration of Zaleplon 5mg and 10mg for the Treatment of Primary Insomnia , 1998 .
[115] D. Beebe,et al. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. , 2003, Sleep.
[116] M. Bonnet,et al. 24-Hour metabolic rate in insomniacs and matched normal sleepers. , 1995, Sleep.
[117] T. Roth,et al. Effects of acute administration of brotizolam in subjects with disturbed sleep. , 1983, British journal of clinical pharmacology.
[118] L. J. Monroe. Psychological and physiological differences between good and poor sleepers. , 1967, Journal of abnormal psychology.
[119] J. Broman,et al. Electrodermal activity in patients with persistent insomnia , 1994, Journal of sleep research.
[120] Daniel J. Buysse,et al. Nonpharmacologic Treatment of Chronic Insomnia , 1999, Sleep.
[121] W. Hao,et al. A Case—Control Study on Psychological Symptoms in Sleep Apnea-Hypopnea Syndrome , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[122] P. Lavie,et al. Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. , 1998, Chest.
[123] Maurice M Ohayon,et al. The effects of breathing-related sleep disorders on mood disturbances in the general population. , 2003, The Journal of clinical psychiatry.
[124] Y. Inoue,et al. Cerebral metabolism in sleep apnea. Evaluation by magnetic resonance spectroscopy. , 1997, American journal of respiratory and critical care medicine.
[125] D. Gozal,et al. Snoring during early childhood and academic performance at ages thirteen to fourteen years. , 2001, Pediatrics.
[126] Jeffry R Alger,et al. Brain morphology associated with obstructive sleep apnea. , 2002, American journal of respiratory and critical care medicine.
[127] G. Chrousos,et al. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. , 2002, Endocrinology and metabolism clinics of North America.
[128] M. Jadoul,et al. Obstructive sleep apnoea , 2002, The Lancet.
[129] C. Soldatos. Insomnia in relation to depression and anxiety: epidemiologic considerations. , 1994, Journal of psychosomatic research.
[130] J. Hedner,et al. Improvement in Neuropsychological Performance Following Surgical Treatment for Obstructive Sleep Apnea Syndrome , 2002, Acta oto-laryngologica.
[131] A. Kales,et al. Severe obstructive sleep apnea--II: Associated psychopathology and psychosocial consequences. , 1985, Journal of chronic diseases.
[132] M Palta,et al. Sleep-disordered breathing and neuropsychological deficits. A population-based study. , 1997, American journal of respiratory and critical care medicine.
[133] S. Ancoli-Israel,et al. Psychological correlates of sleep apnea. , 1999, Journal of psychosomatic research.
[134] G. Simon,et al. Prevalence, burden, and treatment of insomnia in primary care. , 1997, The American journal of psychiatry.
[135] E. Rüther,et al. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia , 2003, Psychopharmacology.